GLP1 Guide
  • Mailing list
  • Medication List
  • Research Roundups
  • Pricing Roundups

Last week in GLP1 (2025/09/22)

  • GLP1.Guide Staff

GLP1.Guide Staff

21 Sep 2025

Here’s what happened last week in the GLP1 ecosystem:

📊 Study: Wegovy pill shows 16.6% weight loss

📢 Eli Lilly says Orforglipron is even better than the Wegovy pill

📺 GLP1s in patch form? Not yet

📑 GLP1s could reduce all-cause mortality by up to 6% by 2045

❓Bariatric surgery more effective than GLP1s?

🗞️ Looking to keep up with GLP1s? We've moved to Substack

GLP1.Guide is now best viewed on Substack: Read the rest on Substack New information is posted there first, and in the future this site will be converted to redirect directly to Substack. Thanks for supporting GLP1.guide, we'll see you over on Substack!
17 Nov 2025
Oral GLP1s you've probably never heard of

Oral GLP1s you've probably never heard of

Most people have heard of Mounjaro, Zepbound, Wegovy, Ozempic and Rybelsus by now. The words “VK2735” or “Orforglipron” mean nothing to most people, though now almost everyone is familiar with GLP1s as a class of drugs (at the very least the effects). There are some obscure GLP1s under development that
15 Oct 2025 1 min read
Last week in GLP1 (2025/10/13)

Last week in GLP1 (2025/10/13)

We’ve gathered some key stories from the GLP1 ecosystem in the last week you might have missed: 🔎 GLP1 interfering with medical imaging? 💚 More research on GLP1’s benefits for stopping substance & alcohol Abuse 📑 Ketones + GLP1s prevent muscle loss (in mice) 🚨 Semaglutide Withdrawal and it’s effects on Type
13 Oct 2025 1 min read
GLP1 Guide © 2026
  • Sign up
Powered by Ghost